Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.48 |
| ▸ | CASP1 | P29466 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.32 |
| ▸ | TUBB | P07437 | 1/20 | 0.32 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.32 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16298546 | 0.91 | TDP1 (0.41) | ALDH1A1TDP1CASP1CYP3A4MAPT | |
| SCHEMBL3690091 | 0.80 | LPL (0.46) | ALDH1A1TDP1CASP1CYP3A4 | |
| SCHEMBL7860034 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TDP1CYP3A4TSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL31547133 | 0.79 | LPL (0.44) | ALDH1A1TDP1CASP1CYP3A4 | |
| SCHEMBL10002183 | 0.75 | POLB (0.32) | POLB | |
| SCHEMBL16298593 | 0.67 | TDP1 (0.41) | ALDH1A1TDP1CASP1CYP3A4MAPT | |
| SCHEMBL16330426 | 0.66 | ACHE (0.47) | ALDH1A1TDP1TSHRLMNA | |
| SCHEMBL5956120 | 0.66 | CASP1 (1.00) | ALDH1A1TDP1CASP1CYP3A4MAPT | |
| SCHEMBL3785245 | 0.66 | MEN1 (0.47) | ALDH1A1TDP1CASP1CYP3A4MAPT | |
| SCHEMBL3783102 | 0.66 | ACHE (0.47) | ALDH1A1TDP1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016146-A1 | POROUS CRYSTAL COMPRISING AMMONIA BORANE AND A PRODUCTION METHOD THEREFOR | INSILICOTECH CO., LTD (KR) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016146-A1 | POROUS CRYSTAL COMPRISING AMMONIA BORANE AND A PRODUCTION METHOD THEREFOR | FAR1, GOT1, WEE1 | ALDH1A1 2659/4885TDP1 3778/4885CASP1 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.